AnPac Bio-Medical Science Co., Ltd. ANPC
Set alert
4.30 0.00 0.00%
As of May 19, 3:59 PM ET
4.25 Day range 4.63
52-week range unavailable
- Open
- 4.57
- Prev close
- 4.30
- Mkt cap
- 26.97M
- Vol
- 35.70K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.25
- High
- 4.63
- Forward P/E
- -6.42
- Beta
- 0.00
- Short ratio
- 2.50
- Inst. own
- 0.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 30, 2023
- 50-d avg
- 5.05
- 200-d avg
- 5.35
- 1y target
- 0.00
Financial health
Altman Z-Score
-26.91 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2017 5y median -4.8× FY 2022
P/S 5.1×
FY 2017 5y median 18.9× FY 2022
P/B -4.5×
FY 2017 5y median -23.4× FY 2022
P/FCF -1.1×
FY 2017 5y median -6.3× FY 2022
EV/EBITDA -0.7×
FY 2017 5y median -5.1× FY 2022
EV/Sales 6.0×
FY 2017 5y median 19.1× FY 2022
FCF Yield -91.8%
FY 2017 5y median -15.9% FY 2022
Profitability
Gross Margin 69.2%
FY 2017 5y median 62.8% FY 2022
Operating Margin -698.6%
FY 2017 5y median -589.6% FY 2022
Net Margin -860.2%
FY 2017 5y median -667.7% FY 2022
ROE 757.5%
FY 2017 5y median 636.2% FY 2022
ROIC -2066.2%
FY 2017 5y median -595.8% FY 2022
ROA -256.0%
FY 2017 5y median -177.9% FY 2022
Growth (YoY)
Revenue -33.0%
FY 2017 FY 2022
Operating Income 20.7%
FY 2017 FY 2022
EPS (diluted) 69.3%
FY 2017 FY 2022
Free Cash Flow 25.1%
FY 2017 FY 2022
Financial Health
Current Ratio 0.3×
FY 2017 5y median 0.3× FY 2022
Quick Ratio 0.3×
FY 2017 5y median 0.3× FY 2022
Debt / Equity -0.9×
FY 2017 5y median -1.2× FY 2022
Net Debt / EBITDA -0.1×
FY 2017 5y median -0.2× FY 2022
Interest Coverage -226×
FY 2017 5y median -47.1× FY 2022
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31